Amorphic mutations in the NF- kappa B essential modulator (NEMO) cause X-dominant incontinentia pigmenti, which is lethal in males in utero, whereas hypomorphic mutations cause X-recessive anhidrotic ectodermal dysplasia with immunodeficiency, a complex developmental disorder and life-threatening primary immunodeficiency. We characterized the NEMO mutation 110_111insC, which creates the most-upstream premature translation termination codon (at codon position 49) of any known NEMO mutation. Surprisingly, this mutation is associated with a pure immunodeficiency. We solve this paradox by showing that a Kozakian methionine codon located immediately downstream from the insertion allows the reinitiation of translation. The residual production of an NH(2)-truncated NEMO protein was sufficient for normal fetal development and for the subsequent normal development of skin appendages but was insufficient for the development of protective immune responses.

The NEMO mutation creating the most-upstream premature stop codon is hypomorphic because of a reinitiation of translation

NOVELLI, Francesco;
2006-01-01

Abstract

Amorphic mutations in the NF- kappa B essential modulator (NEMO) cause X-dominant incontinentia pigmenti, which is lethal in males in utero, whereas hypomorphic mutations cause X-recessive anhidrotic ectodermal dysplasia with immunodeficiency, a complex developmental disorder and life-threatening primary immunodeficiency. We characterized the NEMO mutation 110_111insC, which creates the most-upstream premature translation termination codon (at codon position 49) of any known NEMO mutation. Surprisingly, this mutation is associated with a pure immunodeficiency. We solve this paradox by showing that a Kozakian methionine codon located immediately downstream from the insertion allows the reinitiation of translation. The residual production of an NH(2)-truncated NEMO protein was sufficient for normal fetal development and for the subsequent normal development of skin appendages but was insufficient for the development of protective immune responses.
2006
78
691
701
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16532398
NEMO; NFKB; bacterial infections; immunodeficiency
A. PUEL; J. REICHENBACH; J. BUSTAMANTE; C-L. KU; J. FEINBERG; R. DFFINGER; M. BONNET; O. FILIPE SANTOS; L. DE BEAUCOUDREY; A. DURANDY; G. HORNEFF; F. NOVELLI; V. WAHN; A. SMAHI; A. ISRAEL; T. NIEHUES; J.-L. CASANOVA
File in questo prodotto:
File Dimensione Formato  
NEMO.pdf

Accesso riservato

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 2.73 MB
Formato Adobe PDF
2.73 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/36872
Citazioni
  • ???jsp.display-item.citation.pmc??? 37
  • Scopus 76
  • ???jsp.display-item.citation.isi??? 73
social impact